Thomas Mroz, MD

Appointed
2004

Education & Fellowships

Fellowship - University of California Los Angeles Medical Center
Spinal Surgery
Los Angeles, CA USA
2003

Fellowship - Semmes Murphy Clinic
Neurosurgery
Memphis, TN USA
2003

Residency - The George Washington University School of Medicine & Health Sciences
Orthopaedic Surgery
Washington, DC USA
2002

Internship - The George Washington University School of Medicine & Health Sciences
General Surgery
Washington, DC USA
1998

Medical Education - Case Western Reserve University School of Medicine
MD
Cleveland, OH USA
1997

Undergraduate - Case Western Reserve University
Biology
Cleveland, OH USA
1993

Professional Highlights

• Deputy Editor, Global Spine Journal
• Deputy Editor, The Spine Journal
• Editorial Board, The Spine Journal
• Biologics Board, North American Spine Society
• Research Committee, AO Spine North America
• Patient Education Sub-Committee, Cervical Spine Research Society
• Education Committee, North American Spine Society
• Reviewer, Geriatric Orthopaedic Surgery & Rehabilitation
• Reviewer, Evidence Based Spine Surgery
• Reviewer, Journal of Bone and Joint Surgery
• Reviewer, Cell and Tissue Banking
• Reviewer, Global Spine Journal
• Reviewer, Neurosurgery
• Best Doctors in America, 2010, 2011

Certifications

• Orthopaedic Surgery

Specialty Interests

Cervical Disc Herniation, Cervical Infections, Cervical Myelopathy and Radiculopathy, Cervical Tumors, Complex Cervical Spine Surgery including Cervical Deformity, Minimally Invasive Spine Surgery, Revision Cervical Spine Surgery

Memberships

• American Academy of Orthopaedic Surgery (AAOS)
• American Board of Orthopaedic Surgery (ABOS)
• AOSpine North America
• Cervical Spine Research Society (CSRS)
• North American Spine Society (NASS) 
• Society for Minimally Invasive Spine Surgery (SMISS)

See publications for Thomas Mroz, MD.

(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 9/1/2023, Dr. Mroz has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Mroz receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

• Stryker Corporation

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers' discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.